COVID-19-Induced Hyperleucocytosis in Chronic Lymphocytic Leukaemia

Singh, Balraj and Ayad, Sarah and Kaur, Parminder and Reid,, Ro-Jay and Gupta, Sachin and Maroules, Michael (2021) COVID-19-Induced Hyperleucocytosis in Chronic Lymphocytic Leukaemia. European Journal of Case Reports in Internal Medicine, 8 (3). pp. 1-6. ISSN ISSN: 2284-2594

[img]
Preview
Text
2348-Article Text-21250-1-10-20210312.pdf - Published Version

Download (430kB) | Preview
Official URL: https://www.ejcrim.com/index.php/EJCRIM/issue/view...

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus responsible for the current global pandemic, coronavirus disease 2019 (COVID-19). COVID-19 usually presents with respiratory symptoms but can affect multiple organ systems. A wide spectrum of complications can occur depending upon the comorbidities of patients. There is limited literature available regarding the presentation and outcome of COVID-19 in chronic lymphocytic leukaemia (CLL) patients. We report 2 cases of COVID-19-induced hyperleucocytosis (WBC count >100,000/μl) in CLL patients.

Item Type: Article
Uncontrolled Keywords: COVID-19, SARS-CoV-2, CLL, chronic lymphocytic leukaemia, lymphocytosis, leucocytosis, lymphopenia
Subjects: 600 Tecnologia - Scienze applicate
600 Tecnologia - Scienze applicate > 610 Medicina e salute (Classificare qui la tecnologia dei servizi medici)
600 Tecnologia - Scienze applicate > 610 Medicina e salute (Classificare qui la tecnologia dei servizi medici) > 616 Malattie (classificare qui la Clinica medica, la medicina basata sull'evidenza, la Medicina interna, la Medicina sperimentale)
Depositing User: Marina Spanti
Date Deposited: 21 Dec 2021 14:50
Last Modified: 21 Dec 2021 14:50
URI: http://eprints.bice.rm.cnr.it/id/eprint/21205

Actions (login required)

View Item View Item